5 Small-cap symptoms of yeast infection in men stocks with updates- isx, spx, ppk, net and bit – kalkine media

ISignthis ltd ( ASX: ISX) is an IT-based company engaged in electronic payment verification and transactional banking symptoms of yeast infection in men operations, ensuring a smooth end to end user experience. Its solutions are paydentity™ and isxpay®. The company, which is based out of australia, acts as a principal member of mastercard, chinaunionpay, diners, discover, among others.

Licensing agreement with singaporean unit of visa inc: via a press release dated 8 august 2019, ISX informed regarding a new pact with the singaporean subsidiary symptoms of yeast infection in men of global payments technology company visa inc. Under the australian principal member licensing agreement, ISX would serve as a card acquiring institution for the symptoms of yeast infection in men merchant. Moreover, it would be responsible to process card not present (online/remote) payments and make settlements on behalf of the merchant from symptoms of yeast infection in men cards issued anywhere globally by other visa principal or associate symptoms of yeast infection in men member institutions.

CFO appointment: in an ASX announcement on 31 july 2019, ISX unveiled the appointment of elizabeth warrel for the post symptoms of yeast infection in men of group chief financial officer, effective from 2 september 2019. Elizabeth, who was associated with banking and financial services industry for symptoms of yeast infection in men more than twenty years, would report directly to isignthis ltd CEO john karantzis.

Stock performance: on 12 august 2019, the ISH stock closed the day’s trading at $ 1.060, up 6% from its previous closing price. It has a market capitalisation of $ 1.09 billion and approximately 1.09 billion outstanding shares. The stock has given a good return of 198.51% and 488.24% in the period of last three months and six months, respectively.

A metal & mining company, spectrum metals limited ( ASX: SPX) is headquartered in inglewood. Its ongoing projects are the penny west gold project, in addition to whaleshark copper-gold project and first hit gold project. The company is focusing on brownfield gold asset expansion in symptoms of yeast infection in men western australia, which could add value to its operations. Moreover, it plans to continue high-end drilling and exploration during the coming years.

$ 7.25 million fundraising program: on 1 august 2019, SPX announced to have secured firm commitments regarding a placement symptoms of yeast infection in men to institutional and sophisticated investors. The amount of $ 7.25 million planned to be raised would be utilised for symptoms of yeast infection in men an accelerated exploration program at high-grade penny west/ penny north gold project in western australia, as well as for general working capital purposes. The company would issue 116,000,000 new shares at an issue price of 6.25 cents per fully paid ordinary share. The allotment is as per the company’s 15% capacity under ASX listing rule 7.1.

Stock performance: the stock of SPX has delivered a stellar performance with symptoms of yeast infection in men a positive return of 452.63% and whooping 2000% in the last three and six months, respectively. The SPX stock closed the day’s trading at $ 0.110 on 12 august 2019, up 4.762% from its previous closing price. The company has a market capitalisation of $ 145.48 million and approximately 1.39 billion outstanding shares.

BNNT technology ltd registered with NICNAS: on 1 july 2019, PPK group limited informed investors that according to BNNT technology symptoms of yeast infection in men limited, the latter has registered with the national industrial chemicals notification symptoms of yeast infection in men and assessment scheme (NICNAS). PPK had unveiled the purchase of AICIC in the month symptoms of yeast infection in men of march. AIC investment corporation pty ltd or AICIC holds a stake symptoms of yeast infection in men of 50% of BNNT technology limited. BNNT owns a license contract, enabling the company to produce BNNT or boron nitride nanotubes symptoms of yeast infection in men for 20 years (commercial basis). As BNNT technology limited is a registered manufacturer, it can produce BNNT in australia for commercial purposes.

Fundraising activities: the company, in early june 2019, had announced plans regarding a placement to raise $ 2.75 million for the payment of current loans and to symptoms of yeast infection in men strengthen its balance sheet. Moreover, PPK unveiled that it is holding discussions with a major symptoms of yeast infection in men financial institution for a new funding arrangement to meet increased symptoms of yeast infection in men working capital purposes. For the above placement, PPK is willing to give 1.1 million ordinary shares at an issue price of $ 2.50 per share to sophisticated investors.

Stock performance: the stock of PPK group has delivered a stellar performance symptoms of yeast infection in men with a positive return of 95% and 303.45% in the last three months and six months, respectively. The PPK stock closed the day’s trading at $ 2.250 on 12 august 2019, down 3.846% from its previous closing price. The company has a market capitalisation of $ 193.02 million and approximately 82.49 million outstanding shares.

NetLinkz limited ( ASX: NET) is a technology company providing solutions relating to cloud network. The company provides security systems for all types of organisations. It has been awarded the title of a worldwide winner symptoms of yeast infection in men in the ‘global security challenge’ and several other awards for its technology-driven solutions.

Strategic alliance with beijing digital telecom in china: on 12 august 2019, netlinkz announced that a distributor of netlinkz’s products in the asian country, china, namely JAST limited, reached a deal with henan D. Phone trade corporation limited, which is the wholly owned subsidiary of beijing digital telecom symptoms of yeast infection in men in the henan province.

Under the partnership and agency sales agreement, a cloud services provider model would be developed, using netlinkz’s VIN and VSP products as the core software for symptoms of yeast infection in men that service. The agreement would enable henan D. Phone to offer a secure cloud based private network to symptoms of yeast infection in men existing as well as new customer base. The deal would see JAST sell netlinkz’s products and develop cloud services in the henan province, thereby positioning the former as a true value service provider symptoms of yeast infection in men in this sector.

Collaboration with china communications services: via a media release on 7 august 2019, netlinkz announced that its product distributor in china, JAST limited, entered a strategic alliance with sichuan meixunda communications corporation limited symptoms of yeast infection in men (a 100% owned subsidiary of china communications services corporation limited). Sichuan meixunda communications has access to 20 cities in sichuan symptoms of yeast infection in men province. Moreover, it has 381 retail units with more than 18,00 staff. It is a direct reseller of huawei and samsung.

Stock performance : on 12 august 2019, the stock of NET closed the day’s trading at $ 0.210, down 2.326% from its previous closing price. The company has a market capitalisation of $ 344.48 million and approximately 1.6 billion outstanding shares. The stock has given a return of 147.13% and 667.86% during the last three months and six months, respectively.

Biotron limited ( ASX: BIT) is a health care service provider, associated with the R&D and commercialisation of a novel small molecule approach with symptoms of yeast infection in men potential for the treatment of several viral diseases. The company’s lead compound BIT225 is being developed to treat HIV-1 as well as hepatitis C virus infections. Its headquarters is in sydney.

Quarterly cash flow statement : the company, on 30 july 2019, reported details related to its cash flow position through a symptoms of yeast infection in men media release for the quarter ended 30 june 2019. BIT spent $ 320,000 on R&D, with total operating expense at $ 731,000. Net cash used in investing activities during the period stood symptoms of yeast infection in men at $ 13,000. Cash and cash equivalents at the end of the quarter symptoms of yeast infection in men reached $ 5.71 million. The company expects cash outflows of $ 579,000 during the next quarter ending september 2019.

Stock performance: the stock of BIT closed the day’s trading at $ 0.075 on 12 august 2019, down 3.846% from its previous closing price. The company has a market capitalisation of $ 46.47 million and approximately 595.71 million outstanding shares. The stock has given a negative return of 1.27% and 29.09 % during the past three months and six months, respectively.

This website is a service of kalkine media pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and symptoms of yeast infection in men is not intended to be used as a complete source symptoms of yeast infection in men of information on any particular company. Kalkine media does not in any way endorse or recommend symptoms of yeast infection in men individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

RELATED POSTS